GENE ONLINE|News &
Opinion
Blog

WuXi Biologics
WuXi Biologics, Toregem BioPharma To Develop Tooth-Regenerating Antibody
2022-10-14
WuXi Biologics Launch Its Largest GMP Drug Facility and First Automated Vial Packaging Line
2021-11-03
WuXi Biologics and WuXi STA Establish Joint Venture to Advance Bioconjugates
2021-05-17
WuXi Biologics Completes Three Acquisition Deals to Meet Global Biologics Demands
2021-05-08
Pfizer Sells Manufacturing Facilities in China to WuXi Biologics
2021-03-18
WuXi Biologics Acquires Bayer’s Drug Manufacturing Facility in Wuppertal
2020-12-25
COVID-19 Antibody: Vir Biotechnology Partners with Samsung Biologics for Large Scale Manufacturing
2020-04-15
Weekly in Asia (0519-0525)
2019-05-29
Weekly in Asia(0421-0427 )
2019-04-30
Weekly Top 5 in China (0317-0323)
2019-03-25
Weekly Top 5 in China (0217-0223)
2019-02-22
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top